Product Categories
| Country: | China |
|---|---|
| Tel: | 0758-2716016 |
| Mobile: | 13288804488 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Butanoic acid, 4-bromo-2-(methoxyimino)-3-oxo-, ethyl ester, (Z)- | C7H10BrNO4 | 65872-39-1 | Details |
| Ethyl 2-(2-aminothiazol-4-yl)-2-methoxyiminoacetate | C8H11N3O3S | 64485-88-7 | Details |
| ERYTHROMYCIN OXIME | C37H68N2O13 | 13127-18-9 | Details |
| Cefotaxime Sodium EP Impurity | Details |
| 2,3-DIOXOINDOLINE-5-CARBOXYLIC ACID | C9H5NO4 | 25128-32-9 | Details |
| Cefotaxime Sodium EP Impurity | C16H17N5O7S2 | 63527-52-6 | Details |
| FaMotidine Acid IMpurity | C5H8N4S2.Na | 130463-35-3 | Details |
| Erlotinib Impurity | C22H23N3O5 | 882420-22-6 | Details |
| Ilaprazole Impurity D | Details |
| E-cefotaxime,Cefotaxime Impurity D (EP) | C16H18N5NaO7S2 | 65715-12-0 | Details |
| Ilaprazole Impurity M1Z1 | Details |
| 1-(4-AMINOPHENYL)ETHANOL | C8H11NO | 14572-89-5 | Details |
| Ilaprazole Impurity B | Details |
| Ilaprazole Impurity I | Details |
| 7-Fluoroisatin | C8H4FNO2 | 317-20-4 | Details |
| 2-Deoxy-2,2-difluoro -D-threo-pentonic acid γ-lactone | C5H6F2O4 | 95058-77-8 | Details |
| Ilaprazole Impurity G | Details |
| 5-AMINO-2-FLUOROBENZONITRILE | C8H6FN | 77123-60-5 | Details |
| 1-(3,5-Dimethoxyphenyl)propan-2-one | C11H14O3 | 18917-77-6 | Details |
| 1-(4-Methoxybenzyl)-1h-pyrazol-5-amine | C11H13N3O | 3528-45-8 | Details |
| 5-Nitronaphthalene-1-boronic acid | C16H18BNO4 | 885007-62-5 | Details |
| Ilaprazole Impurity E | Details |
| Dabigatran | C25H25N7O3 | 211914-51-1 | Details |
| 6-Iodo-2-methyl-1,3-benzothiazole | C8H6INS | 68867-20-9 | Details |
| 4-(2-Hydroxyethyl)phenylboronicacid | C8H11BO3 | 137756-89-9 | Details |
| (R)-tert-Butyl methyl(pyrrolidin-3-yl)carbamate | C10H20N2O2 | 392338-15-7 | Details |
| Dabigatran Etexilate | C27H29N7O3 | 429658-95-7 | Details |
| 2-Pyrimidinecarboxaldehyde | C5H4N2O | 27427-92-5 | Details |
| 3-(4-Methylimidazol-1-yl)-5-trifluoromethylbenzoic acid | C12H9F3N2O2 | 641571-13-3 | Details |
| Ilaprazole Impurity H | Details |
| ALPHA-CYCLOPROPYLBENZYL ALCOHOL | C10H12O | 1007-03-0 | Details |
| FaMotidine Acid IMpurity | C8H15N7O2S3 | Details |
| 1-(oxetan-3-yl)piperazine hydrochloride | C7H15ClN2O | 1369338-92-0 | Details |
| METHYL (3S)-3-AMINO-3-PHENYLPROPANOATE | C10H13NO2 | 37088-66-7 | Details |
| [3-[[[2-(DiaMinoMethyleneaMino)-4-thiazolyl]Methyl]thio]propionyl]sulfaMide Hydrochloride (FaMotidine IMpurity) | C8H15ClN6O3S3 | 76824-17-4 | Details |
| FaMotidine sulfoxide | C8H15N7O3S3 | Details |
| N,N'''-[2H-1,2,4,6-Thiatriazine-3,5-diylbis(2,1-ethanediylthiomethylene-4,2-thiazolediyl)]bisguanidine S,S-dioxide (Z)-2-butenedioate (1:2) | C24H31N11O10S5 | 109467-08-5 | Details |
| Nilotinib Impurity 7 | C27H20F3N7O | 2119583-26-3 | Details |
| FMOC-1,4-DIAMINOBUTANE HYDROCHLORIDE | C19H23ClN2O2 | 321660-77-9 | Details |
| FaMotidine iMpurity B | C8H15N7O2S3 | Details |
| Nitrosamine impurities | Details |
| 3-(3-FLUOROPHENYL)PROPIONIC ACID | C9H9FO2 | 458-45-7 | Details |
| 1,4-Dibutyrylpiperazine | 17730-78-8 | Details |
| FaMotidine iMpurity D | C8H15N7O2S3 | Details |
| Ibubinib impurity | Details |
| 2-Methylnaphthalene-1-boronic Acid | C11H11BO2 | 103989-84-0 | Details |
| N-Acetyl-L-citrulline | C8H15N3O4 | 33965-42-3 | Details |
| 3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamidine | C8H15N7O3S3 | 90237-03-9 | Details |
| FaMotidine Acid IMpurity | C8H12N4O2S2 | 107880-74-0 | Details |
| ETHYL 2-(HYDROXYIMINO)-3-OXOBUTANOATE | C6H9NO4 | 5408-04-8 | Details |
| 2,4-DIMETHYL PYRROL-3-CARBALDEHYDE | C7H9NO | 2199-62-4 | Details |
| Nilotinib Impurity | C10H12N2O | 123367-26-0 | Details |
| FaMotidine iMpurity C | C8H15N7O2S3 | Details |
| Piperazine impurity | Details |
| 2,3,4,5,6-PENTAFLUOROBENZENEBORONIC ACID | C6H2BF5O2 | 1582-24-7 | Details |
| Glycine, N-(2,6-dimethylphenyl)- | C10H13NO2 | 103095-36-9 | Details |
| 2-Pyridinecarboxylicacid,4,5,6-trichloro- | C6H2Cl3NO2 | 496849-77-5 | Details |
| Butanoic acid, 4-bromo-2-(hydroxyimino)-3-oxo-, ethyl ester | C6H8BrNO4 | 75689-07-5 | Details |
| TERT-BUTYL 8-BROMO-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE | C14H18BrNO2 | 893566-75-1 | Details |
| 2-amino-6-methylpyridin-3-ol | C6H8N2O | 20348-16-7 | Details |
| 6-METHYLPYRIDINE-2-BORONIC ACID | C6H8BNO2 | 372963-50-3 | Details |
| 4,4'-AZOXYDIBENZOIC ACID | C14H10N2O5 | 582-69-4 | Details |
| Pyridine, 5-ethynyl-2-methoxy- (9CI) | C8H7NO | 663955-59-7 | Details |
| AZEPANE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER | C12H21NO4 | 1034708-26-3 | Details |
| Cefetamet hydrochloride | C14H15N5O5S2 | 65052-63-3 | Details |
| ErythroMycin A 6,9-IMino Ether | C37H66N2O12 | 99290-97-8 | Details |
| Diethyl aminomalonate hydrochloride | C7H14ClNO4 | 13433-00-6 | Details |
| CLOPIDOGREL RELATED COMPOUND B (20 MG) (METHYL(+/-)-(O-CHLOROPHENYL)-4,5-DIHYDROTHIE-NO[2,3-C]PYRIDINE-6(7H)-ACETATE, HYDROCHLORIDE) | C16H16ClNO2S.ClH | 144750-52-7 | Details |
| 2-carbaldehyde-1,4-naphthoquinone | C13H6O4 | 189763-05-1 | Details |
| (Z)-2-(Methoxyimino)-3-oxo-butanoic Acid Ethyl Ester | C7H11NO4 | 66340-86-1 | Details |
| 3-Desacetyl CefotaxiMe Lactone | C14H13N5O5S2 | 66340-33-8 | Details |
| 3'-N,N-Di(desMethyl)-3'-N-forMyl AzithroMycin | C37H68N2O13 | 765927-71-7 | Details |
| 4-Hydroxybenzoic acid | C7H6O3 | 99-96-7 | Details |
| Cabozantinib Impurity LKLY | Details |
| Sodium methylparaben | C8H9NaO3 | 5026-62-0 | Details |
| sitafloxacin hydrate Impurity | C19H18ClF2N3O3 | 127254-11-9 | Details |
| sitafloxacin hydrate Impurity 3 | Details |
| Flunarizine Impurity 2 | C22H26N2 | 88172-16-1 | Details |
| DT-4 self-condensation product | Details |
| Cefotaxime Sodium EP Impurity C | C17H17N5O8S2 | 66403-32-5 | Details |
| Butanoic acid, 2-(hydroxyimino)-3-oxo-, ethyl ester, (2Z)- | C6H9NO4 | 66508-93-8 | Details |
| Relugolix Impurity | Details |
| sitafloxacin hydrate Impurity | Details |
| Cabozantinib Impurity EXA | C17H14F2N2O2 | 1431468-36-8 | Details |
| N-Methoxyethanamide | C3H7NO2 | 5806-90-6 | Details |
| desacetylcefotaxime | C14H15N5O6S2 | 66340-28-1 | Details |
| DT-6 by-product 4S, 5R | Details |
| Benzaldehyde | C7H6O | 100-52-7 | Details |
| 2,3-dihydroxypropyl 4-hydroxybenzoate | C10H12O5 | 93778-15-5 | Details |
| Azithromycin EP Impurity P | C39H74N2O12 | 92594-45-1 | Details |
| 2-carboxylic acid-1,4-naphthoquinone | C13H6O5 | 1133287-34-9 | Details |
| Clopidogrel Metabolite | Details |
| 3-Quinolinecarboxylic acid, 6,7- difluoro-1-(2-fluorocyclopropyl)-1,4- dihydro-4-oxo-, cis-(+)- (9CI) | C13H8F3NO3 | 127199-00-2 | Details |
| 3'-Des(diMethylaMino)-3'-keto AzithroMycin | C36H65NO13 | 612069-25-7 | Details |
| 1-(Oxetan-3-yl)piperazine | C7H14N2O | 1254115-23-5 | Details |
| Cabozantinib Impurity CB | Details |
| METHYL 3-AMINO-5-METHOXYBENZOATE | C9H11NO3 | 217314-47-1 | Details |
| 7-[(4S)-4-Amino-6-azaspiro[2.4]heptan-6-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid | C19H18ClF2N3O3 | 127254-10-8 | Details |
| FaMotidine AMide IMpurity | C8H13N5OS2 | 76824-16-3 | Details |
| N-Methoxy-N,3-Dimethylbutanamide | C7H15NO2 | 147356-77-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 | ||||